A CD300c-Fc Fusion Protein Inhibits T Cell Immunity
T cell responses are fine-tuned by co-stimulatory and co-inhibitory molecules. Among the T cell regulators, the B7 family members are of central importance. The recent success in targeting the B7 family molecules for the treatment of immune-related diseases has attracted intense interest in identify...
Main Authors: | Cheng Cui, Min Su, Yujun Lin, Laijun Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02657/full |
Similar Items
-
Identification of TAPBPL as a novel negative regulator of T‐cell function
by: Yujun Lin, et al.
Published: (2021-05-01) -
Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes
by: Min Su, et al.
Published: (2019-08-01) -
Graft immune cell composition associates with clinical outcome of allogeneic hematopoietic stem cell transplantation in patients with AML
by: Ulla Impola, et al.
Published: (2016-11-01) -
Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges
by: Moutuaata M. Moutuou, et al.
Published: (2018-06-01) -
Administration of Recombinant TAPBPL Protein Ameliorates Collagen-Induced Arthritis in Mice
by: Zhenzhen Zhang, et al.
Published: (2023-09-01)